Lung cancer drug approval: Is it the best option for patients?
Lung cancer drug approval is a significant milestone for Alembic Pharma, enhancing treatment options.
Cancer Drug Price Cuts: Smart Move to Save Rs 3,502 Crore
Cancer drug price cuts are set to save Rs 3,502 crore annually, benefiting patients and healthcare.
Cancer Drug Prices: Clear Path to 70% Savings Ahead
Cancer drug prices could see a significant drop of up to 70% due to government action.






